Meld评分的优点及局限性

Advantages and Limitations of Meld Scoring

Meld评分系统自2000年以来一直被Malinchoc教授用于评估晚期肝病。分数得到了充分的发展和提高。主要衡量指标是结合医院常见的实验室指标和非实验室指标,通过一定的统计方法进行计算,并结合对晚期肝病患者预后起关键作用的临床指标。因此出现了Meld-Plus的概念。然而,大量的研究结果表明,Meld-Plus比单一的评分更具优势,这也将是未来熔合评分的发展趋势和前景。目前,该评分仍有一定的局限性。大量研究表明,许多临床患者有明显的肝移植手术证据,但最终评分与实际情况相差较大。Meld评分结合其他实验室指标和临床体征将成为未来的趋势。

The Meld scoring system has been used by Professor Malinchoc to assess advanced liver disease since 2000. Scores have been fully developed and improved, mainly in the accuracy and accuracy of the scores. The main indicators are calculated by combining common laboratory indicators and non-laboratory indicators in hospitals with certain statistical methods, and combined with clinical indicators that play a key role in the prognosis of patients with advanced liver disease. Hence, the concept of Meld-Plus appears. However, a large number of research results show that Meld-Plus has more advantages than single score, which will be the development trend and prospect of fusion score in the future. At present, the score still has some limitations. A large number of studies have shown that many clinical patients have obvious evidence of liver transplantation surgery, but the final score differs greatly from the actual situation. Meld scores combined with other laboratory in-dicators and clinical signs will become a trend in the future.